Inventor · disambiguated record
Yi-Qun Shi
Also filed as: SHI I YI · SHI YI · SHI YI-QUN
71 granted patents·30 pending applications·636 citations·filing 1994–2024
99Inventor score
Files withPALATIN TECHNOLOGIES INC32VERTEX PHARMA23ABBVIE INC7UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION5UNIV JEFFERSON4
Top patents by PatentIndex Score
101 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0397US9862709B2Processes for making compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2015·Granted Jan 9, 2018·16 cites·36 claims
- 0497US9035053B2Processes for making compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted May 19, 2015·21 cites·24 claims
- 0596US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0695US8614299B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideBAURIN NICOLAS·Filed 2010·Granted Dec 24, 2013·56 cites·27 claims
- 0793US7968548B2Melanocortin receptor-specific piperazine compounds with diamine groupsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 28, 2011·19 cites·16 claims
- 0891US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0991US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1091US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 1191US7342089B2Cyclic peptides for treatment for cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 11, 2008·21 cites·18 claims
- 1290US10208027B2Processes for preparing ATR inhibitorsVERTEX PHARMA·Filed 2017·Granted Feb 19, 2019·3 cites·20 claims
- 1389US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 1489US8877890B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2013·Granted Nov 4, 2014·8 cites·27 claims
- 1589US8492517B2Melanocortin-1 receptor-specific cyclic peptidesYANG WEI·Filed 2012·Granted Jul 23, 2013·8 cites·10 claims
- 1689US7345144B2Cyclic peptides for treatment of cachexiaPALATIN TECHNOLOGIES INC·Filed 2005·Granted Mar 18, 2008·15 cites·16 claims
- 1788US9333204B2Solid antiviral dosage formsABBVIE INC·Filed 2015·Granted May 10, 2016·5 cites·15 claims
- 1888US7727991B2Substituted melanocortin receptor-specific single acyl piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·8 cites·15 claims
- 1988US7354923B2Piperazine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Apr 8, 2008·26 cites·50 claims
- 2088US7326707B2Bicyclic melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Feb 5, 2008·23 cites·56 claims
- 2187US10822331B2Processes for preparing ATR inhibitorsVERTEX PHARMA·Filed 2018·Granted Nov 3, 2020·2 cites·35 claims
- 2287US8846601B2Melanocortin receptor-specific peptidesSHI YI-QUN·Filed 2011·Granted Sep 30, 2014·5 cites·12 claims
- 2387US8455617B2Melanocortin receptor-specific peptidesDODD JOHN H·Filed 2010·Granted Jun 4, 2013·9 cites·6 claims
- 2487US8263608B2Melanocortin receptor-specific spiro-piperidine compoundsSHI YI-QUN·Filed 2011·Granted Sep 11, 2012·15 cites·15 claims
- 2587US7718802B2Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 18, 2010·6 cites·34 claims
- 2686US9771361B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Sep 26, 2017·8 cites·48 claims
- 2786US8729224B2Melanocortin receptor-specific peptides for treatment of female sexual dysfunctionPALATIN TECHNOLOGIES INC·Filed 2013·Granted May 20, 2014·7 cites·9 claims
- 2886US7709484B1Substituted melanocortin receptor-specific piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted May 4, 2010·8 cites·19 claims
- 2986US7456184B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Nov 25, 2008·24 cites·15 claims
- 3085US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 3185US10711039B2Melanocortin receptor-specific peptide with C-terminal naphthylalaninePALATIN TECHNOLOGIES INC·Filed 2018·Granted Jul 14, 2020·1 cites·17 claims
- 3285US10017539B2Melanocortin-1 receptor-specific cyclic hexapeptidesPALATIN TECHNOLOGIES INC·Filed 2016·Granted Jul 10, 2018·3 cites·20 claims
- 3385US9744170B2Solid antiviral dosage formsABBVIE INC·Filed 2016·Granted Aug 29, 2017·3 cites·20 claims
- 3485US8247530B2N-alkylated cyclic peptide melanocortin agonistsSHARMA SHUBH D·Filed 2006·Granted Aug 21, 2012·10 cites·20 claims
- 3585US7727990B2Melanocortin receptor-specific piperazine and keto-piperazine compoundsPALATIN TECHNOLOGIES INC·Filed 2006·Granted Jun 1, 2010·6 cites·20 claims
- 3684US9447148B2Melanocortin-1 receptor-specific cyclic peptidesPALATIN TECHNOLOGIES INC·Filed 2014·Granted Sep 20, 2016·4 cites·30 claims
- 3784US8487073B2Melanocortin receptor-specific peptides for treatment of sexual dysfunctionSHI YI-QUN·Filed 2010·Granted Jul 16, 2013·7 cites·12 claims
- 3884US8455618B2Melanocortin receptor-specific peptidesDODD JOHN H·Filed 2011·Granted Jun 4, 2013·6 cites·6 claims
- 3983US9040663B2Melanocortin receptor-specific peptidesASTRAZENECA AB·Filed 2013·Granted May 26, 2015·4 cites·11 claims
- 4083US8933194B2Melanocortin-1 receptor-specific linear peptidesYANG WEI·Filed 2012·Granted Jan 13, 2015·5 cites·11 claims
- 4183US7964601B2Melanocortin receptor-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2008·Granted Jun 21, 2011·6 cites·17 claims
- 4283US7385025B2Metallopeptide compoundsPALATIN TECHNOLOGIES INC·Filed 2005·Granted Jun 10, 2008·2 cites·10 claims
- 4381US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 4480US10112991B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2016·Granted Oct 30, 2018·2 cites·30 claims
- 4580US10106578B2Melanocortin-1 receptor-specific linear peptidesPALATIN TECHNOLOGIES INC·Filed 2017·Granted Oct 23, 2018·2 cites·7 claims
- 4680US7834017B2Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituentsPALATIN TECHNOLOGIES INC·Filed 2007·Granted Nov 16, 2010·5 cites·10 claims
- 4780US7189755B2Pyrrolidine melanocortin-specific compoundsPALATIN TECHNOLOGIES INC·Filed 2004·Granted Mar 13, 2007·9 cites·12 claims
- 4880US6323184B1Arteriovenous and venous graft treatments: methods and compositionsUNIV JEFFERSON·Filed 1995·Granted Nov 27, 2001·55 cites·29 claims
- 4979US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 5079US10195297B2Iron garnet nanoparticles for cancer radiotherapy and chemotherapyUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH·Filed 2017·Granted Feb 5, 2019·1 cites·11 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →